These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology. Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578 [TBL] [Abstract][Full Text] [Related]
6. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets. Rossi M; Abdelmohsen K Cells; 2021 Jul; 10(7):. PubMed ID: 34359910 [TBL] [Abstract][Full Text] [Related]
7. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies. Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070 [TBL] [Abstract][Full Text] [Related]
8. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S Elife; 2022 May; 11():. PubMed ID: 35507395 [TBL] [Abstract][Full Text] [Related]
9. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Lagoumtzi SM; Chondrogianni N Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756 [TBL] [Abstract][Full Text] [Related]
10. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction. Nehlin JO Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979 [TBL] [Abstract][Full Text] [Related]
11. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care. Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431 [TBL] [Abstract][Full Text] [Related]
12. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases. Matsubayashi S; Ito S; Araya J; Kuwano K Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349 [TBL] [Abstract][Full Text] [Related]
13. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation. Wong PF; Dharmani M; Ramasamy TS Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835 [TBL] [Abstract][Full Text] [Related]
14. Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics. Riessland M; Orr ME J Prev Alzheimers Dis; 2023; 10(4):633-646. PubMed ID: 37874084 [TBL] [Abstract][Full Text] [Related]
15. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Khalil R; Diab-Assaf M; Lemaitre JM Cells; 2023 Mar; 12(6):. PubMed ID: 36980256 [TBL] [Abstract][Full Text] [Related]
18. Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models. Inci N; Kamali D; Akyildiz EO; Tahir Turanli E; Bozaykut P Front Aging; 2022; 3():828058. PubMed ID: 35821852 [TBL] [Abstract][Full Text] [Related]
19. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology. Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619 [TBL] [Abstract][Full Text] [Related]